Matches in Wikidata for { <http://www.wikidata.org/entity/Q103837953> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q103837953 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 3ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q103837953 description "article scientifique publié en 2020" @default.
- Q103837953 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q103837953 description "scientific article published on 03 December 2020" @default.
- Q103837953 description "wetenschappelijk artikel" @default.
- Q103837953 description "наукова стаття, опублікована 3 грудня 2020" @default.
- Q103837953 name "Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance" @default.
- Q103837953 name "Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance" @default.
- Q103837953 name "Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance" @default.
- Q103837953 type Item @default.
- Q103837953 label "Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance" @default.
- Q103837953 label "Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance" @default.
- Q103837953 label "Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance" @default.
- Q103837953 prefLabel "Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance" @default.
- Q103837953 prefLabel "Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance" @default.
- Q103837953 prefLabel "Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance" @default.
- Q103837953 P1433 Q103837953-36547833-7074-4CF7-B2C0-EE7496932EF6 @default.
- Q103837953 P1476 Q103837953-3C0BF6A0-2ADB-4375-AB9E-38C57B00BDA4 @default.
- Q103837953 P2093 Q103837953-1A028B23-C97C-4585-81BD-65A71D0B6D2F @default.
- Q103837953 P2093 Q103837953-38E669AF-EC74-494C-9160-9A76008FA37C @default.
- Q103837953 P2093 Q103837953-A7CEFC4C-3129-4D5E-9D14-5C6C09914CCA @default.
- Q103837953 P2093 Q103837953-EB1E7513-CA6F-44AB-A923-BD5478C3DF8E @default.
- Q103837953 P275 Q103837953-D6955533-0CD8-4305-AE5A-89F8A56EAC43 @default.
- Q103837953 P31 Q103837953-D111CFC6-223A-42C3-9AF7-47A6E39A522B @default.
- Q103837953 P356 Q103837953-55E72DF9-AC71-48F3-A814-5D6D9E887714 @default.
- Q103837953 P50 Q103837953-86052973-A98F-46EA-B535-F63A197C0F11 @default.
- Q103837953 P50 Q103837953-FD983949-1ACD-49C4-8404-A9C857BCD216 @default.
- Q103837953 P577 Q103837953-A86890C3-07CD-4E36-99D7-DF328A6FA30D @default.
- Q103837953 P6216 Q103837953-478E92A3-C9C7-415F-A388-8B9B09E1D241 @default.
- Q103837953 P698 Q103837953-C7947C60-FC76-4DBA-BB35-9DD59E3D04B6 @default.
- Q103837953 P921 Q103837953-45B9342D-F035-4BA0-954E-5ACEEE1A86A9 @default.
- Q103837953 P921 Q103837953-B1E045D5-5A5A-4A8A-8A1D-6098DD9802A4 @default.
- Q103837953 P356 14740338.2021.1859477 @default.
- Q103837953 P698 33269625 @default.
- Q103837953 P1433 Q5421206 @default.
- Q103837953 P1476 "Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance" @default.
- Q103837953 P2093 "Kaori Ochiai" @default.
- Q103837953 P2093 "Naoki Shimmoto" @default.
- Q103837953 P2093 "Naoyuki Hayashi" @default.
- Q103837953 P2093 "Tomoo Okamura" @default.
- Q103837953 P275 Q24082749 @default.
- Q103837953 P31 Q13442814 @default.
- Q103837953 P356 "10.1080/14740338.2021.1859477" @default.
- Q103837953 P50 Q103837952 @default.
- Q103837953 P50 Q86762910 @default.
- Q103837953 P577 "2020-12-03T00:00:00Z" @default.
- Q103837953 P6216 Q50423863 @default.
- Q103837953 P698 "33269625" @default.
- Q103837953 P921 Q3025883 @default.
- Q103837953 P921 Q909745 @default.